How to buy Celularity stock (GXGX)

Celularity is a shell companies business based in the US. Celularity shares (GXGX) are listed on the NASDAQ and all prices are listed in US Dollars.

Our top picks for where to buy Celularity stock

Buy Celularity stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Celularity stock price (NASDAQ: GXGX)

Use our graph to track the performance of GXGX stocks over time.

Celularity shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$10.06
200-day moving average more info button	$10.14
Wall St. target price	N/A
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.49

Is it a good time to buy Celularity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Celularity financials

Gross profit TTM	$0
Return on assets TTM	-1.29%
Return on equity TTM	-52.61%
Profit margin	0%
Book value	$0.67
Market Capitalization more info button	$201.6 million

TTM: trailing 12 months

Celularity share dividends

We're not expecting Celularity to pay a dividend over the next 12 months.

Celularity overview

Celularity Inc. , a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey. .

Frequently asked questions

null
What percentage of Celularity is owned by institutions?
Currently 83.535% of Celularity shares are held by institutions. When does the fiscal year end for Celularity?
Celularity's fiscal year ends in December. Where is Celularity based?
Celularity's address is: 170 Park Ave, Florham Park, NJ, United States, 07932 What is Celularity's ISIN number?
Celularity's international securities identification number is: US1511901050 What is Celularity's CUSIP number?
Celularity's Committee on Uniform Securities Identification Procedures number is: 36251A107